Funding C2i Genomics Raises $100 Million To Commercialize the Detection of Tiny Traces of Cancer Using AI and Whole Genome Sequencing
Devices Aloe Care Health Partners With BioIntelliSense To Integrate Groundbreaking Continuous Vital Sign Monitoring For Scalable Remote Patient Care
Devices Nerivio Wearable Migraine Therapeutic Now Eligible for Coverage through UpScript’s Telemedicine Platform